Watchlist
Loading...
US Stock MarketDetailed Quotes

SGEN Seagen

Watchlist
214.160 -0.260-0.12% Close 11/28 16:00 ET
214.690High213.840Low873.89KVolume
Pre-Market
  • 5D
  • 1D
  • 1W
  • 1M
  • 1Q
  • 1Y

About Seagen Company

Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA.

Revenue Breakdown

Business Unit:USD
2022/12/31
Stock NameRevenueRatio
Net product sales1.71B86.96%
Collaboration and license agreement revenues164.55M8.39%
Royalty revenues91.34M4.65%

Comments

Read more
Paper Trade Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Claim up to $1 million virtual fund, join moomoo paper trading today! Claim Now >